Drug Search Results
More Filters [+]

CR-20

Alternative Names: cr-20, cr20, cr 20
Latest Update: 2024-04-27
Latest Update Note: PubMed Publication

Product Description

a reuterin-producing strain (Sourced from: https://pubmed.ncbi.nlm.nih.gov/19640313/)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Universidad Complutense de Madrid
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for CR-20

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Mastitis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Promast08

P3

Completed

Mastitis

2008-07-01

Recent News Events